Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 23 studies | 33% ± 18% | |
endothelial cell | 18 studies | 34% ± 17% | |
astrocyte | 17 studies | 41% ± 18% | |
macrophage | 17 studies | 39% ± 20% | |
microglial cell | 15 studies | 54% ± 18% | |
naive B cell | 14 studies | 24% ± 5% | |
oligodendrocyte precursor cell | 14 studies | 34% ± 13% | |
glutamatergic neuron | 13 studies | 67% ± 24% | |
memory B cell | 12 studies | 21% ± 5% | |
GABAergic neuron | 11 studies | 49% ± 23% | |
ciliated cell | 10 studies | 29% ± 14% | |
dendritic cell | 10 studies | 42% ± 19% | |
pericyte | 9 studies | 26% ± 10% | |
retinal cone cell | 9 studies | 72% ± 24% | |
club cell | 8 studies | 25% ± 10% | |
retinal rod cell | 8 studies | 55% ± 30% | |
myeloid cell | 8 studies | 38% ± 13% | |
smooth muscle cell | 8 studies | 26% ± 8% | |
non-classical monocyte | 7 studies | 24% ± 6% | |
neuron | 7 studies | 46% ± 13% | |
respiratory goblet cell | 6 studies | 38% ± 20% | |
conventional dendritic cell | 6 studies | 25% ± 7% | |
amacrine cell | 6 studies | 34% ± 18% | |
epithelial cell | 6 studies | 28% ± 8% | |
interneuron | 6 studies | 51% ± 15% | |
retinal ganglion cell | 6 studies | 45% ± 15% | |
basal cell | 6 studies | 27% ± 11% | |
fibroblast | 6 studies | 29% ± 18% | |
T cell | 6 studies | 32% ± 8% | |
retinal bipolar neuron | 5 studies | 51% ± 19% | |
immature B cell | 5 studies | 29% ± 6% | |
retina horizontal cell | 5 studies | 41% ± 20% | |
CD4-positive, alpha-beta T cell | 5 studies | 29% ± 7% | |
CD8-positive, alpha-beta T cell | 5 studies | 22% ± 4% | |
adipocyte | 5 studies | 21% ± 3% | |
mast cell | 5 studies | 29% ± 13% | |
monocyte | 5 studies | 55% ± 14% | |
cholangiocyte | 4 studies | 45% ± 19% | |
granule cell | 4 studies | 55% ± 26% | |
precursor B cell | 4 studies | 29% ± 8% | |
mesothelial cell | 4 studies | 34% ± 10% | |
OFF-bipolar cell | 4 studies | 59% ± 24% | |
ON-bipolar cell | 4 studies | 54% ± 23% | |
natural killer cell | 4 studies | 34% ± 7% | |
leukocyte | 4 studies | 54% ± 11% | |
secretory cell | 3 studies | 22% ± 3% | |
hepatic stellate cell | 3 studies | 50% ± 17% | |
GABAergic interneuron | 3 studies | 43% ± 11% | |
progenitor cell | 3 studies | 37% ± 8% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 24% ± 5% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 22% ± 8% | |
pro-B cell | 3 studies | 27% ± 2% | |
cardiac muscle cell | 3 studies | 20% ± 3% | |
mononuclear phagocyte | 3 studies | 35% ± 10% | |
GABAergic amacrine cell | 3 studies | 53% ± 13% | |
glycinergic amacrine cell | 3 studies | 26% ± 7% | |
rod bipolar cell | 3 studies | 72% ± 23% | |
endothelial cell of vascular tree | 3 studies | 26% ± 4% | |
hepatocyte | 3 studies | 61% ± 25% | |
connective tissue cell | 3 studies | 26% ± 8% | |
ependymal cell | 3 studies | 37% ± 21% | |
hematopoietic stem cell | 3 studies | 23% ± 2% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 33% ± 9% | |
alveolar macrophage | 3 studies | 60% ± 3% | |
lymphocyte | 3 studies | 42% ± 3% | |
goblet cell | 3 studies | 41% ± 20% | |
type I pneumocyte | 3 studies | 17% ± 0% | |
type II pneumocyte | 3 studies | 54% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 8135.17 | 2557 / 2642 | 99% | 33.41 | 701 / 705 |
thymus | 99% | 2612.69 | 648 / 653 | 95% | 17.49 | 574 / 605 |
pancreas | 100% | 2949.34 | 328 / 328 | 83% | 9.78 | 147 / 178 |
lung | 96% | 1784.56 | 555 / 578 | 86% | 18.93 | 993 / 1155 |
intestine | 100% | 2365.03 | 964 / 966 | 82% | 12.41 | 431 / 527 |
bladder | 100% | 2026.19 | 21 / 21 | 76% | 12.90 | 385 / 504 |
breast | 86% | 1395.25 | 395 / 459 | 89% | 13.50 | 998 / 1118 |
esophagus | 99% | 2110.18 | 1427 / 1445 | 77% | 13.62 | 140 / 183 |
prostate | 95% | 1691.39 | 232 / 245 | 64% | 5.90 | 323 / 502 |
uterus | 76% | 1041.05 | 129 / 170 | 79% | 12.47 | 363 / 459 |
liver | 83% | 1224.46 | 188 / 226 | 71% | 10.70 | 287 / 406 |
ovary | 53% | 652.19 | 95 / 180 | 89% | 16.37 | 381 / 430 |
adrenal gland | 54% | 623.67 | 140 / 258 | 86% | 14.13 | 197 / 230 |
stomach | 39% | 730.38 | 140 / 359 | 76% | 12.12 | 217 / 286 |
kidney | 27% | 309.45 | 24 / 89 | 80% | 10.48 | 721 / 901 |
skin | 72% | 3751.34 | 1308 / 1809 | 30% | 2.85 | 140 / 472 |
spleen | 100% | 2729.50 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.43 | 1 / 1 |
adipose | 98% | 2047.98 | 1181 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 1500.19 | 1246 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 4359.18 | 861 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 18.85 | 41 / 45 |
lymph node | 0% | 0 | 0 / 0 | 76% | 11.38 | 22 / 29 |
heart | 59% | 1506.26 | 505 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 13% | 1.26 | 10 / 80 |
muscle | 3% | 30.38 | 24 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032793 | Biological process | positive regulation of CREB transcription factor activity |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0006954 | Biological process | inflammatory response |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0071622 | Biological process | regulation of granulocyte chemotaxis |
GO_0050773 | Biological process | regulation of dendrite development |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0090023 | Biological process | positive regulation of neutrophil chemotaxis |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0060267 | Biological process | positive regulation of respiratory burst |
GO_0007399 | Biological process | nervous system development |
GO_0005622 | Cellular component | intracellular anatomical structure |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0004683 | Molecular function | calmodulin-dependent protein kinase activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CAMK1D |
Protein name | Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK) Calcium/calmodulin-dependent protein kinase ID, isoform CRA_b (Calcium/calmodulin-dependent protein kinase type 1D variant 2) (Calcium/calmodulin-dependent protein kinase type 1D variant 3) (cDNA FLJ76987, highly similar to Homo sapiens calcium/calmodulin-dependent protein kinase ID (CAMK1D), transcript variant 1, mRNA) |
Synonyms | CAMKID hCG_1811212 |
Description | FUNCTION: Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, activates CREB-dependent gene transcription, regulates calcium-mediated granulocyte function and respiratory burst and promotes basal dendritic growth of hippocampal neurons. In neutrophil cells, required for cytokine-induced proliferative responses and activation of the respiratory burst. Activates the transcription factor CREB1 in hippocampal neuron nuclei. May play a role in apoptosis of erythroleukemia cells. In vitro, phosphorylates transcription factor CREM isoform Beta. . |
Accessions | ENST00000378845.5 [Q8IU85-2] ENST00000619168.5 [Q8IU85-1] Q8IU85 Q5SQQ7 |